Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K U Bartz-Schmidt

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
The British Journal of Ophthalmology|February 24, 2004
Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg retina flowmetryC P Jonescu-Cuypers, A Harris, K U Bartz-Schmidt, et al.
Cancer Research|April 20, 2001
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanomaF Tschentscher, G Prescher, D E Horsman, et al.
The British Journal of Ophthalmology|October 8, 2008
Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisationO Tatar, K Shinoda, E Kaiserling, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)], F Ziemssen, H Helbig, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 26, 2015
[Immunotherapy of uveal melanoma: vaccination against cancer. Multicenter adjuvant phase 3 vaccination study using dendritic cells laden with tumor RNA for large newly diagnosed uveal melanoma]B Schuler-Thurner, K-U Bartz-Schmidt, N Bornfeld, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
The British Journal of Ophthalmology|February 24, 2004
Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg retina flowmetryC P Jonescu-Cuypers, A Harris, K U Bartz-Schmidt, et al.
Cancer Research|April 20, 2001
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanomaF Tschentscher, G Prescher, D E Horsman, et al.
The British Journal of Ophthalmology|October 8, 2008
Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisationO Tatar, K Shinoda, E Kaiserling, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)], F Ziemssen, H Helbig, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 26, 2015
[Immunotherapy of uveal melanoma: vaccination against cancer. Multicenter adjuvant phase 3 vaccination study using dendritic cells laden with tumor RNA for large newly diagnosed uveal melanoma]B Schuler-Thurner, K-U Bartz-Schmidt, N Bornfeld, et al.
Pageof 18